Here, we used transcriptomic data from The Cancer Genome Atlas (TCGA) to evaluate the prognostic value of TERT and adaptive immune B and T cells in 11 cancer types, including those with accepted HPV pathogenesis and those with prevalent mutations in the TERT promoter region. This evidence concerns the gene TERT and cancer.